基于人工智能的抗胆碱能负担评估新工具:一项调查
研究开发了基于自然语言处理和化学结构分析的在线工具IACT,并于2021年2月8日至3月31日调查临床医生对该类工具的需求及IACT的可用性。共收到来自不同国家和执业群体的110份回复,86.11%的参与者表示若有抗胆碱能负担评估工具会使用;34名对IACT与其他工具进行比较的回复者中,20.59%认为更好,8.82%认为显著更好,44.12%认为既不更好也不更差。结论是临床需要抗胆碱能负担计算器,IACT有潜力满足该需求。
要点
- 86.11%的受访临床医生表示若有抗胆碱能负担评估工具会使用。
- 34名比较者中20.59%认为IACT更好,8.82%认为显著更好。
- IACT基于自然语言处理和化学结构分析,可为现有及新上市药物评分。
核心结论
- 临床需要抗胆碱能负担计算器来评估药物的抗胆碱能效应。
- IACT有潜力满足该需求,因其可基于化学结构和报告的不良药理效应为现有及新上市药物评分。
研究设计与样本
- 开发基于自然语言处理和化学结构分析的在线工具IACT,并于2021年2月8日至3月31日开展调查评估工具需求及IACT可用性。
- 共收到来自不同国家和执业群体的110份调查回复。
主要发现
- 86.11%的参与者表示若有抗胆碱能负担评估工具会使用。
- 34名回复者将IACT与其他工具比较,20.59%认为更好,8.82%认为显著更好,44.12%认为既不更好也不更差,14.71%认为更差,11.76%认为稍差。
关键数值与推荐
- 目前有超过20种工具可供临床医生评估抗胆碱能负担,但对其最合适工具尚无共识。
临床怎么用
- 临床医生可使用抗胆碱能负担评估工具识别抗胆碱能副作用高风险人群。
- IACT可作为评估现有及新上市药物抗胆碱能负荷的潜在工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: many medications possess anticholinergic activity. Their use is associated with a number of serious adverse effects including cognitive effects. The cumulative anticholinergic effect of medications as assessed by tools such as the anticholinergic burden scale (AchB) can identify people particularly at risk of anticholinergic side-effects. Currently, >20 tools are available for clinicians to use, but there is no consensus on the most appropriate tool. METHODS: a newly created online tool-International Anticholinergic Cognitive Burden Tool (IACT)-based on natural language processing and chemical structure analysis, was developed and made available for clinicians to test its functions. We carried out a survey (between 8th of February and 31st of March 2021) to assess the overall need for an assessment tool as well as the usability of the IACT. RESULTS: a total of 110 responses were received from different countries and practitioners' groups. The majority of the participants (86.11%) stated they would use a tool for AchB assessment if available and when they were asked to rate the IACT against other tools, amongst 34 responders, 20.59% rated it better and 8.82% rated it significantly better, 44.12% rated it neither better, nor worse, 14.71% rated it worse and 11.76% somewhat worse. CONCLUSION: there is a need for an anticholinergic burden calculator to assess the anticholinergicity of medications. Tools such as the IACT potentially could meet this demand due to its ability to assign scores to current and new medications appearing on the market based both on their chemical structure and reported adverse pharmacological effects.
引用
- Secchi A, Mamayusupova H, Sami S, et al. A novel Artificial Intelligence-based tool to assess anticholinergic burden: a survey. Age Ageing. 2022. PMID: 36029230. doi:10.1093/ageing/afac196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。